Felix Study Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Felix Study Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Felix Study Data Today - Breaking & Trending Today

Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study

Published: December 20, 2023

Claire Roddie, MD, PhD, presents data from the pooled analysis of the ongoing FELIX phase Ib/II study investigating obecabtagene autoleucel in patients with relapsed/refractory adult B-cell acute lymphoblastic leukemia.

Source: onclive.com

Related Topics:

San DiegoUnited StatesObecabtagene AutoleucelClaire RoddiePooled AnalysisClin OncolMedian DorFelix StudyObe CelCart Cell TherapyCar TFelix TrialFelix Study DataRelapsed Refractoryb AllRelapsed Refractoryb Cell Acute Lymphoblastic Leukemia